Skip to main content

Jason C. Vigna


[email protected]



Jason Vigna has extensive experience representing clients in more than seventy complex securities, commercial and corporate governance matters in trial and appellate courts throughout the country and before the SEC. He has helped technology companies, life sciences companies, asset management firms and other sophisticated businesses -- and their officers and directors -- successfully resolve disputes involving a wide variety of stockholder- and fraud-related claims.

Jason has not only worked on some of the largest securities fraud cases in history (including Worldcom and the "IPO laddering" cases), but also the defense of nearly a dozen small or mid-sized life sciences companies wrongly accused of misleading investors. His track record includes the successful defense of an asset management company in dozens of class, derivative, bankruptcy and individual actions arising out of hedge fund investments made with Bernard Madoff; the successful defense of the former CEO and the former general counsel of the then-largest broker on the Chicago Mercantile Exchange in consolidated actions arising out of the broker’s collapse; and representation of the special litigation committee of the then-largest insurance company in the world in an investigation of allegations that senior officers breached fiduciary duties in connection with a $4 billion accounting restatement.

Jason's current clients include a major European private equity fund, a cryptocurrency exchange and a large real estate development company. He is ranked by Chambers USA, has been a preferred securities defense counsel panel member for multiple insurance companies and brokers and, in 2022, 2019 and 2017, was a Legal 500 "Recommended Attorney." Published client testimonials call Jason "[c]reative, dedicated, smart and efficient," "always available," “detail-oriented," "a really good creative writer and thinker in the space," and "an excellent attorney with a deep understanding of securities litigation and [an] appreciation for litigation strategy" "[whose] advice blends the legal, commercial and practical."

Prior to joining Mintz, Jason was a partner at another large law firm, where he helped clients resolve disputes involving federal and state stockholder- and fraud-related statutes, including the Securities Exchange Act of 1934, the Securities Act of 1933, the Racketeering Influenced and Corrupt Organizations (RICO) Act and the Delaware General Corporation Law. He also represented clients in commercial litigation and fights over the control of closely-held companies.

In addition to U.S. clients, Jason has represented numerous foreign companies, including several from Israel and others from Bermuda, Canada, China, England, Germany, Ireland, Italy, Kazakhstan, Luxembourg and Singapore.

Before entering private practice, Jason clerked for the Honorable J.P. Stadtmueller of the US District Court for the Eastern District of Wisconsin.


  • Defended the officers of a prominent Israeli manufacturing company against securities claims that the officers knowingly misrepresented the performance of a business unit accused of bribery. Achieved complete pleadings-stage dismissal with prejudice of all claims, which sought over $1 billion in damages.
  • Defended a national physical therapy clinic operator against a putative securities class action that alleged the company's accounting restatement resulted from a knowing mischaracterization of noncontrolling interests in individual clinics. The court dismissed all the allegations with prejudice, finding plaintiffs had alleged no facts from which fraudulent intent could be inferred.
  • Defended a well-known technology company and its directors against consolidated lawsuits that claimed the defendants omitted material information from a proxy statement filed in connection with its merger with another well-known company. Negotiated a limited disclosure-based settlement of all claims before the scheduled stockholder vote, which occurred without incident.
  • After another law firm failed to secure a pleadings-stage dismissal, assumed the defense of an international bank accused of misleading investors about the value of its bonds, in alleged violation of the Securities Exchange Act. Following aggressive fact and expert discovery, obtained complete victory on summary judgment and subsequent affirmance in the Second Circuit Court of Appeals.
  • Defended a pharmaceutical company and its officers against a putative securities class action lawsuit alleging that defendants mischaracterized the likelihood that the company would receive FDA approval to sell its leading drug candidate. Convinced the plaintiffs to drop the suit without any settlement consideration.
  • Defended the former CEO and former general counsel of the largest broker on the then Chicago Mercantile Exchange (now the CME Group) against consolidated actions related to the collapse of the company. Obtained complete dismissal prior to discovery.
  • Defended the world's largest cannabis company in a wide-ranging Delaware books and records lawsuit. Obtained complete dismissal in a ruling that judicially construed the phrase "business day" for the first time in Delaware history.
  • Represented a global defense technology company in a multipronged dispute with former officers of its largest subsidiary and obtained pretrial settlement.
  • Prepared the debt underwriters of a US-based telecommunications company for a trial involving allegations that they defrauded buyers of the company’s bonds.
  • Defended a global financial services provider in a trial and appeal involving allegations that the company committed fraud and breached a contract in connection with the sale of a subsidiary. Secured dismissal of the most significant claims.
  • Represented a special litigation committee of what was then the world’s largest insurance company in an investigation of allegations that senior officers had breached fiduciary duties to the company.
  • Defended a global financial and travel-related services company against allegations of illegal trading of the securities of a company where one of the defendant’s executives served on the board. Obtained complete dismissal pre-discovery and ultimately secured a token settlement.
Read less


On August 10, 2023, the U.S. Court of Appeals for the Second Circuit took an important step in Arkansas Teacher Retirement System v. Goldman Sachs Group toward clarifying the circumstances in which federal class action plaintiffs can – and cannot – rely on mere presumptions to proceed to the merits phases of logically weak securities fraud cases.
Read more
In our sixth session, the team is joined by Jason Vigna, a Member in our Securities Litigation Practice, to discuss best practices for handling crises in the boardroom — including identifying, documenting, discussing, managing, and disclosing material risks.
Read more
In 2021, approximately on quarter of all federal securities fraud class action lawsuits filed nationwide were against life sciences companies and their officers and directors. These considerations are for directors and officers of life sciences companies looking to manage disclosures and mitigate risk before a suit ever gets filed.
Read more
Read less

News & Press

Press Release Thumbnail
BOSTON – Mintz has earned top rankings in the 2023 edition of Legal 500 United States guide. The firm is recognized in 14 practice categories, and 59 individual attorneys are also recognized in the guide, some in more than one category.
Press Release Thumbnail
BOSTON –Mintz announced today that 39 of its practices and 81 of its attorneys earned recognition in the 2023 edition of Chambers USA, a guide to the country’s leading law firms.
Press Release Thumbnail
Mintz achieved a significant victory for BTA Bank (BTA) on January 18, when the U.S. Court of Appeals for the Second Circuit affirmed summary judgment dismissing all claims against BTA in a nearly decade-long securities fraud lawsuit alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. This decisive issue of what loss causation evidence a holder of thinly-traded securities must present to prove such claims was a matter of first impression in the Second Circuit.
News Thumbnail
The American Banker reported that Home Bancshares filed a supplemental proxy filing detailing its proposed acquisition of Happy Bancshares after a disaffected investor filed suit seeking more information about how Home Bancshares arrived at the deal's $919 million price tag. In the article, Mintz Member Jason Vigna provided insights on these types of merger-objection suits, including with regards to both outcomes for stockholders and venue shifts.
News Thumbnail
Mintz Member Jason Vigna was quoted extensively in an article published by MarketWatch on Didi Global after the Chinese government blocked new users from downloading the app, causing shares to fall more than 20%. Specifically, he discussed whether the company's broad disclosure of regulatory risks in it's F-1 is enough to prevent the SEC and private investors from successfully taking action against the company for failure to disclose a specific ongoing investigation into the company, or other violations of securities law.
Press Release Thumbnail
The New York Law Journal highlighted the arrival of Jason Vigna as a Member in Mintz’s Securities Litigation Practice in New York. The article also included commentary from Managing Member Bob Bodian on the firm’s sixth consecutive year of revenue gains and the additions of four litigators in the firm’s New York office over the last year, including Members Courtney Rockett, Jeremy Vest, Suman Chakraborty, and Douglas Baumstein.
Read less

Events & Speaking


Liability for Security Law Violations

Understanding the Securities Laws 2022 PLI Conference

New York, NY

Conference Reference Image
Read less

Recognition & Awards

  • Chambers USA: New York - Litigation: Securities (2021 - 2023)
  • Recommended by the Legal 500 United States for Dispute Resolution: Securities Litigation – Defense (2017, 2019, 2022, 2023)
Read less


  • Member, Legal, Compliance & Regulatory Forum, BioNJ. (2018 – 2020)
  • Member, Audit Committee Chair Advisory Council, National Association of Corporate Directors (2017)
Read less